vatalanib has been researched along with zm 336372 in 1 studies
| Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (zm 336372) | Trials (zm 336372) | Recent Studies (post-2010) (zm 336372) |
|---|---|---|---|---|---|
| 276 | 42 | 98 | 27 | 0 | 11 |
| Protein | Taxonomy | vatalanib (IC50) | zm 336372 (IC50) |
|---|---|---|---|
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 100 | |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.0603 | |
| Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (house mouse) | 0.57 | |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.23 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.18 | |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | 2 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 1.09 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for vatalanib and zm 336372
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |